Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization

por Hu, Ying, Chen, Wenming, Chen, Shilun, Huang, Zhongxia
Publicado 2016

Analysis of clinical features, treatment response, and prognosis among 61 elderly newly diagnosed multiple myeloma patients: a single-center report

por An, Na, Li, Xin, Shen, Man, Chen, Shilun, Huang, Zhongxia
Publicado 2015

Analysis of the Metabolic Characteristics of Serum Samples in Patients With Multiple Myeloma

por Du, Haiwei, Wang, Linyue, Liu, Bo, Wang, Jinying, Su, Haoxiang, Zhang, Ting, Huang, Zhongxia
Publicado 2018

Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma

por Wei, Yujun, Wang, Jinying, Chen, Fei, Li, Xin, Zhang, Jiajia, Shen, Man, Tang, Ran, Huang, Zhongxia
Publicado 2022

Ixazomib‐based maintenance therapy after bortezomib‐based induction in patients with multiple myeloma not undergoing transplantation: A real‐world study

por Shen, Man, Zhang, Jiajia, Tang, Ran, Wang, Yuhao, Zhan, Xiaokai, Fan, Sibin, Huang, Zhongxia, Zhong, Yuping, Li, Xin
Publicado 2021

Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma

por Leng, Yun, Qiu, Lugui, Hou, Jian, Zhao, Yaozhong, Zhang, Xuejun, Yang, Shifang, Xi, Hao, Huang, Zhongxia, Pan, Ling, Chen, Wenming
Publicado 2016

Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma

por Painuly, Utkarsh, Ramakrishnan, Vijay, Kimlinger, Teresa, Wellik, Linda, Haug, Jessica, Gonsalves, Wilson, Bi, Lintao, Huang, Zhongxia, Rajkumar, S. Vincent, Kumar, Shaji
Publicado 2018

P925: PHASE 1 TRIAL OF ANTI-CD38 MONOCLONAL ANTIBODY CM313 IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA OR LYMPHOMA

por Chen, Wenming, Huang, Zhongxia, Fang, Baijun, Song, Yuqin, Jing, Hongmei, Xia, Zhongjun, Cai, Zhen, An, Gang, Zhou, Huixing, Liu, Nian, LI, Xin, Liu, Yuzhang, Ping, Lingyan, Wan, Wei, Chen, Xiaoqin, He, Jingsong, Xu, Yan
Publicado 2023

Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placeb...

por Xia, Zhongjun, Leng, Yun, Fang, Baijun, Liang, Yang, Li, Wei, Fu, Chengcheng, Yang, Linhua, Ke, Xiaoyan, Jiang, Hua, Weng, Jianyu, Liu, Li, Zhao, Yaozhong, Zhang, Xuejun, Huang, Zhongxia, Liu, Aichun, Shi, Qingzhi, Gao, Yuhuan, Chen, Xiequn, Pan, Ling, Cai, Zhen, Wang, Zhao, Wang, Yafei, Fan, Yaqun, Hou, Ming, Ma, Yigai, Hu, Jianda, Liu, Jing, Zhou, Jianfeng, Zhang, Xiaohong, Meng, Haitao, Lu, Xuzhang, Li, Fei, Ren, Hanyun, Huang, Bintao, Shao, Zonghong, Zhou, Hebing, Hu, Yu, Yang, Shifang, Zheng, Xiangjun, Wei, Peng, Pang, Hongyan, Yu, Wei, Liu, Yuzhang, Gao, Sujun, Yan, Lingzhi, Ma, Yanping, Jing, Hongmei, Du, Juan, Ling, Wei, Zhang, Jingyi, Sui, Weiwei, Wang, Fuxu, Li, Xin, Chen, Wenming
Publicado 2023